
Advancements and Challenges in Stem Cell-Derived Islet Therapies for Type 1 Diabetes
Abstract Type 1 diabetes (T1D) is a complex autoimmune disorder characterized by the progressive and irreversible destruction of insulin-producing beta cells within the pancreatic islets of Langerhans. This cellular devastation leads to absolute insulin deficiency […]